The top 100 venture investors in biotech 2026
The top 100 venture investors in biotech 2026 by Endpoints News: 2 venture firms ranked, led by OrbiMed. The entries on record, movement since the last edition...
- Publisher
- Endpoints News
- Published
- February 26, 2026
- On this page
- 2 of 100 ranked
- Method
- Data
- Reliability
- Grade A
OrbiMed jumped to first after more than doubling its deal activity to $5.9 billion in 2025; RA Capital Management dropped to second. Tracked biopharma venture investment totaled $28.6 billion.
The list on record
This page shows the 2 entries on record of 100 published. Only the top two are visible outside the sign-up wall. See the original list.
| Rank | Name | Since 2025 |
|---|---|---|
| 1 | OrbiMedRound value usd bn: 5.9 | |
| 2 | RA Capital Management | Down 1 |
This list is reproduced as Endpoints News published it. Names are shown as printed. The ranking belongs to its publisher.
Sources and known limits
A reviewed date is not available for this page.